Autocrine signaling extends PD-L1 expression in NSCLC following an active immune response

被引：0
|
作者：
Bursell, Taylor M.
Prabhakaran, Sandhya
Luddy, Kimberly
Pineriro, Julian
Bravo, Rafael
West, Jeffrey
Robertson-Tessi, Mark
Beg, Aner
Gray, Jhanelle
Antonia, Scott
Gatenby, Robert
Anderson, Alexander
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-124
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
124
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PD-L1 expression in NSCLC
    Janzic, U.
    Kern, I.
    Janzic, A.
    Cavka, L.
    Cufer, T.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S58 - S59
  • [2] Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti-PD-L1)
    Kowanetz, Marcin
    Zou, Wei
    Gettinger, Scott N.
    Koeppen, Hartmut
    Kockx, Mark
    Schmid, Peter
    Kadel, Edward E., III
    Wistuba, Ignacio
    Chaft, Jamie
    Rizvi, Naiyer A.
    Spigel, David R.
    Spira, Alexander
    Hirsch, Fred R.
    Cohen, Victor
    Smith, Dustin
    Boyd, Zach
    Miley, Natasha
    Flynn, Susan
    Leveque, Vincent
    Shames, David S.
    Ballinger, Marcus
    Mocci, Simonetta
    Shankar, Geetha
    Funke, Roel
    Hampton, Garret
    Sandler, Alan
    Amler, Lukas
    Mellman, Ira
    Chen, Daniel S.
    Hegde, Priti S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (43) : E10119 - E10126
  • [3] PD-L1 expression in NSCLC and biopsy size
    Kern, I.
    Kovacevic, M.
    Janzic, U.
    Cufer, T.
    VIRCHOWS ARCHIV, 2016, 469 : S127 - S127
  • [4] Patterns of PD-L1 expression and tumor infiltrating immune cells in resected NSCLC
    Gureviciene, Giedre
    Matulione, Jurgita
    Poskiene, Lina
    Miliauskas, Skaidrius
    Zemaitis, Marius
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [5] PREVALENCE AND PROGNOSTIC ASSOCIATION OF PD-L1 PROTEIN AND IMMUNE GENE EXPRESSION IN NSCLC
    Kowanetz, Marcin
    Shames, David S.
    Koeppen, Hartmut
    Xiao, Yuanyuan
    Behrens, Carmen
    Desai, Rupal
    Fu, Ling
    Chappey, Colombe
    Mokatrin, Ahmad
    Kadel, Edward E.
    Do, An
    Brustugun, Odd Terje
    D'Arcangelo, Manolo
    Boyle, Theresa
    Chen, Daniel S.
    Hampton, Garret
    Amler, Lukas C.
    Hirsch, Fred R.
    Hegde, Priti S.
    Wistuba, Ignacio I.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S377 - S377
  • [6] Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors
    Janning, Melanie
    Kobus, Franca
    Babayan, Anna
    Wikman, Harriet
    Velthaus, Janna-Lisa
    Bergmann, Sonja
    Schatz, Stefanie
    Falk, Markus
    Berger, Lars-Arne
    Boettcher, Lisa-Marie
    Paesler, Sarina
    Gorges, Tobias M.
    O'Flaherty, Linda
    Hille, Claudia
    Joosse, Simon A.
    Simon, Ronald
    Tiemann, Markus
    Bokemeyer, Carsten
    Reck, Martin
    Riethdorf, Sabine
    Pantel, Klaus
    Loges, Sonja
    CANCERS, 2019, 11 (06):
  • [7] Efficacy of PD-1/PD-L1 Immune Checkpoint Inhibitors for Advanced NSCLC According to PD-L1 Expression: A Meta-Analysis
    Ma, K.
    Guo, Y.
    Wang, Y.
    Wang, X.
    Xu, Y.
    Sun, C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S584 - S584
  • [8] Response to salvage chemotherapy following exposure to PD-1/PD-L1 inhibitors in patients with NSCLC
    Rothschild, S. I.
    Leger, P.
    Castellanos, E. L.
    Pillai, R. N.
    York, S. J.
    Horn, L.
    ANNALS OF ONCOLOGY, 2017, 28
  • [9] PD-L1 expression as a predictor of postoperative recurrence and the association between the PD-L1 expression and EGFR mutations in NSCLC
    Kojima, Kensuke
    Sakamoto, Tetsuki
    Kasai, Takahiko
    Kagawa, Tomoko
    Yoon, Hyungeun
    Atagi, Shinji
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [10] Efficacy comparison of immune treating strategies for NSCLC patients with negative PD-L1 expression
    Ding, Kaiyue
    Yi, Minhan
    Liang, Hui
    Li, Zhongkui
    Zhang, Yuan
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2022, 18 (07) : 759 - 771
12345